132 related articles for article (PubMed ID: 19574981)
1. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
Lonardo A; Loria P
Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
[No Abstract] [Full Text] [Related]
2. [Fatty liver: frequent and not completely harmless].
Lang C; Georgi A; Gubler C
Praxis (Bern 1994); 2013 Sep; 102(18):1089-101. PubMed ID: 24005067
[No Abstract] [Full Text] [Related]
3. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
Füessl HS
MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
[No Abstract] [Full Text] [Related]
4. Alcoholic and nonalcoholic forms of fatty liver disease.
Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease and cardiovascular risk.
Brea A; Puzo J
Int J Cardiol; 2013 Aug; 167(4):1109-17. PubMed ID: 23141876
[TBL] [Abstract][Full Text] [Related]
6. Medical consequences of obesity.
Lawrence VJ; Kopelman PG
Clin Dermatol; 2004; 22(4):296-302. PubMed ID: 15475229
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
Rafiq N; Younossi ZM
Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
Edens MA; Kuipers F; Stolk RP
Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in elderly.
Yeolekar ME
J Assoc Physicians India; 2000 Nov; 48(11):1045-6. PubMed ID: 11310376
[No Abstract] [Full Text] [Related]
10. [Schizophrenia increases risk of diabetes and cardiovascular diseases].
Hintikka J; Niskanen L
Duodecim; 2005; 121(7):705-7. PubMed ID: 15909958
[No Abstract] [Full Text] [Related]
11. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
Schindhelm RK; Heine RJ; Diamant M
Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
[No Abstract] [Full Text] [Related]
12. Liver manifestations in systemic lupus erythematosus: high incidence of hemophagocytic syndrome.
Tsuji T; Ohno S; Ishigatsubo Y
J Rheumatol; 2002 Jul; 29(7):1576-7. PubMed ID: 12136926
[No Abstract] [Full Text] [Related]
13. Prognostic utility of RIFLE for acute renal failure in patients with sepsis.
Lopes JA; Jorge S; Resina C; Santos C; Pereira A; Neves J; Antunes F; Prata MM
Crit Care; 2007; 11(2):408. PubMed ID: 17430577
[No Abstract] [Full Text] [Related]
14. Fatty liver and liver transplantation.
Koehler E; Watt K; Charlton M
Clin Liver Dis; 2009 Nov; 13(4):621-30. PubMed ID: 19818309
[TBL] [Abstract][Full Text] [Related]
15. [Renal malfunction and cardiovascular diseases].
Koivuviita N; Tertti R; Metsarinne K
Duodecim; 2006; 122(2):237-42. PubMed ID: 16509074
[No Abstract] [Full Text] [Related]
16. Steatohepatitis and apoptosis: therapeutic implications.
Feldstein A; Gores GJ
Am J Gastroenterol; 2004 Sep; 99(9):1718-9. PubMed ID: 15330908
[No Abstract] [Full Text] [Related]
17. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
[TBL] [Abstract][Full Text] [Related]
18. Editorial comment.
El Nahas M
Nephron Clin Pract; 2010; 114(2):c103. PubMed ID: 20191694
[No Abstract] [Full Text] [Related]
19. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
